MDGL
MADRIGAL PHARMACEUTICALS, INC.
NASDAQ · Healthcare · Biotechnology · US
$531.52
−0.54%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 80.71x
- P/E 2028E
- 22.36x
- P/S forward
- 6.77x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 23.45x
- Price / sales
- 9.56x
- Price / cash flow
- -62.11x
Enterprise value
- Enterprise value
- $11.8B
- EV / sales
- 9.18x
- EV / EBITDA
- -39.46x
- EV / EBIT
- -36.54x
- Market cap
- $12.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026